New hope for inoperable lung cancer: experimental combo shows promise
Disease control
Completed
This study tested whether adding two new drugs (GFH018 and toripalimab) to standard chemotherapy and radiation could better control advanced, inoperable stage III lung cancer. It involved 65 patients who had not received prior treatment for this stage of cancer. The main goal was…
Phase: PHASE2 • Sponsor: Genfleet Therapeutics (Shanghai) Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC